Pharmaceutical Imports To Outpace Exports

Hong Kong's negative pharmaceutical trade balance is forecast to widen over the next five years. The main drivers are increased imports of affordable generic medicines from mainland China at the expense of local production and moderation of demand for expensive patented drugs from abroad. Through to 2014, BMI projects compound annual growth rates (CAGRs) in pharmaceutical imports and exports of 8.86% and 9.11%

To read the full article, please choose one of the following options: